Reengineered

Turbine's Virtual Lab puts 2.5 trillion simulated experiments at your fingertips, allowing you to rapidly generate novel hypotheses at scale

ADC PAYLOADS

Turbine simulates payloads to match your ADC to the right patients

[contact-form-7 id="d07d7ea" title="Services form" html_id="services-form" html_class="services-form"]

TARGET ID

Turbine uncovers novel targets to expand your pipeline

[contact-form-7 id="d07d7ea" title="Services form" html_id="services-form" html_class="services-form"]

Scientists have more ideas than ever - our simulation platform helps pick the right ones

Data science-augmented R&D

Many hypotheses. Hard to pick.

Simulation-aided R&D

Decision engine to select best ideas

Simulations let you design more experiments to get a more comprehensive answer

50M+ experiments / day

Engineer any sample to simulate
Test all relevant perturbations

more less

Simulations are a mechanism engine, showing "why" something occurs

Mechanistic hypotheses lead to a 50% higher likelihood of validation

Select experiments based on mechanistic readouts from our translational toolkit
Fail wrong ideas early with Turbine’s in-house validation assays

more less

Simulations base every decision on evidence, boosting PoS

2x faster timeline from scientific question to validation

Integrate pharma knowledge
Fit into existing processes

more less

Drag / scroll horizontally for more

R&D is full of choices - we helped partners make the right ones, repeatedly

TARGET
DISCOVERY

COMBINATION
DESIGN

BIOMARKER
SELECTION

DISEASE
POSITIONING

DRUG
PHARMACOLOGY

INDICATION
EXPANSION

Simulations have shown impact in various programs, at multiple stages of R&D

APPLICATION AREAS

TARGET
DISCOVERY

DRUG
DISCOVERY

PRECLINICAL

EARLY
DEVELOPMENT

DEVELOPMENT AND
COMMERCIALIZATION

TARGET DISCOVERY

LATEST NEWS

TARGET DISCOVERY

LIG4

TARGET DISCOVERY

NEK1

BIOMARKER SELECTION

DISEASE POSITIONING

CDC7

COMBINATION DESIGN

WEE1

BIOMARKER SELECTION

COMBINATION DESIGN

BIOMARKER SELECTION

DISEASE POSITIONING

Top pharma partner

COMBINATION DESIGN

DISEASE POSITIONING

PUBLICATION

Target Discovery & De-risking
(OLD) ADC payloads
(OLD) Clinical positioning
(OLD) DDR

Clear Filters

DAVID M. RUBIN _PhD

Managing Director of MSD Global Health Innovation Fund

“We believe Turbine’s Simulated Cell has the potential to transform key aspects of the oncology drug discovery and development process, providing insight at scale that will shed light on even the most challenging biological mechanisms.”

SEISHI KATSUMATA

Corporate Officer / Executive Director, Discovery & Research of Ono Pharmaceutical

"Turbine has provided multiple targets that have first-in-class potential, along with the biology-driven insights necessary to rapidly validate this potential."

TOM LOUNIBOS

Global Managing Director of Accenture Ventures

"Turbine’s AI-based platform has clearly demonstrated the ability to unlock high-quality biological insights for our clients across the biopharma industry."

ALAN BARGE

ex VP and Head of Oncology and Infection at AstraZeneca

“Turbine can fundamentally change the way in which novel targets in precision oncology are identified.”

Simulate experiments in Turbine's Virtual Lab

Turbine's Virtual Lab puts 2.5 trillion simulated experiments at your fingertips, allowing you to rapidly generate novel hypotheses at scale

Scientists have more ideas than ever - our simulation platform helps pick the right ones

Data science-augmented R&D

Many hypotheses. Hard to pick.

Simulation-aided R&D

Decision engine to select best ideas

R&D is full of choices - we helped partners make the right ones, repeatedly

Simulations have shown impact in various programs, at multiple stages of R&D

Results you can trust quickly delivered, seamlessly integrated into your workflow

PARTNERS AND INVESTORS